Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 078119
Company: CIPLA LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/21/2017 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/078119s000TAltr.pdf

ABACAVIR SULFATE

TABLET;ORAL; EQ 300MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription No AB 201570 APOTEX INC
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription No AB 077844 AUROBINDO PHARMA LTD
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription No AB 078119 CIPLA LTD
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription No AB 091560 HETERO LABS LTD III
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription No AB 091294 MYLAN PHARMS INC
ABACAVIR SULFATE ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription No AB 091050 STRIDES PHARMA
ZIAGEN ABACAVIR SULFATE EQ 300MG BASE TABLET;ORAL Prescription Yes AB 020977 VIIV HLTHCARE

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English